Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Age related macular degeneration
|
390 | 0.645 | 0.560 | 1 | 196673103 | missense variant | G/A | snv | 0.32 | 0.40 | 0.900 | 0.980 | 48 | 2005 | 2019 | ||||
Exudative age-related macular degeneration
|
45 | 0.645 | 0.560 | 1 | 196673103 | missense variant | G/A | snv | 0.32 | 0.40 | 0.740 | 1.000 | 4 | 2014 | 2017 | ||||
Polypoidal choroidal vasculopathy
|
67 | 0.645 | 0.560 | 1 | 196673103 | missense variant | G/A | snv | 0.32 | 0.40 | 0.100 | 1.000 | 12 | 2008 | 2017 | ||||
Glycogen storage disease type II
|
80 | 0.645 | 0.560 | 1 | 196673103 | missense variant | G/A | snv | 0.32 | 0.40 | 0.100 | 1.000 | 10 | 2008 | 2018 | ||||
Central Serous Chorioretinopathy
|
10 | 0.645 | 0.560 | 1 | 196673103 | missense variant | G/A | snv | 0.32 | 0.40 | 0.020 | 0.500 | 2 | 2016 | 2018 | ||||
Lupus Erythematosus, Systemic
|
635 | 0.645 | 0.560 | 1 | 196673103 | missense variant | G/A | snv | 0.32 | 0.40 | 0.020 | 1.000 | 2 | 2011 | 2011 | ||||
Membranoproliferative Glomerulonephritis, Type II
|
3 | 0.645 | 0.560 | 1 | 196673103 | missense variant | G/A | snv | 0.32 | 0.40 | 0.020 | 1.000 | 2 | 2008 | 2011 | ||||
Reticular pseudodrusen
|
10 | 0.645 | 0.560 | 1 | 196673103 | missense variant | G/A | snv | 0.32 | 0.40 | 0.020 | 1.000 | 2 | 2014 | 2018 | ||||
Retinal angiomatous proliferation
|
4 | 0.645 | 0.560 | 1 | 196673103 | missense variant | G/A | snv | 0.32 | 0.40 | 0.020 | 1.000 | 2 | 2010 | 2017 | ||||
Retinal pigment epithelium atrophy
|
2 | 0.645 | 0.560 | 1 | 196673103 | missense variant | G/A | snv | 0.32 | 0.40 | 0.020 | 1.000 | 2 | 2016 | 2017 | ||||
Acute anterior uveitis
|
30 | 0.645 | 0.560 | 1 | 196673103 | missense variant | G/A | snv | 0.32 | 0.40 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Acute central serous chorioretinopathy
|
3 | 0.645 | 0.560 | 1 | 196673103 | missense variant | G/A | snv | 0.32 | 0.40 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Alzheimer's Disease
|
968 | 0.645 | 0.560 | 1 | 196673103 | missense variant | G/A | snv | 0.32 | 0.40 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Anterior uveitis
|
10 | 0.645 | 0.560 | 1 | 196673103 | missense variant | G/A | snv | 0.32 | 0.40 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Atypical Hemolytic Uremic Syndrome
|
31 | 0.645 | 0.560 | 1 | 196673103 | missense variant | G/A | snv | 0.32 | 0.40 | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||
Choroidal vascular hyperpermeability
|
3 | 0.645 | 0.560 | 1 | 196673103 | missense variant | G/A | snv | 0.32 | 0.40 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
Diabetes
|
611 | 0.645 | 0.560 | 1 | 196673103 | missense variant | G/A | snv | 0.32 | 0.40 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
Diabetes Mellitus
|
714 | 0.645 | 0.560 | 1 | 196673103 | missense variant | G/A | snv | 0.32 | 0.40 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
Diabetic Retinopathy
|
159 | 0.645 | 0.560 | 1 | 196673103 | missense variant | G/A | snv | 0.32 | 0.40 | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||
Disseminated Intravascular Coagulation
|
3 | 0.645 | 0.560 | 1 | 196673103 | missense variant | G/A | snv | 0.32 | 0.40 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
Geographic Atrophy
|
32 | 0.645 | 0.560 | 1 | 196673103 | missense variant | G/A | snv | 0.32 | 0.40 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Glomerulonephritis, Membranoproliferative
|
3 | 0.645 | 0.560 | 1 | 196673103 | missense variant | G/A | snv | 0.32 | 0.40 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
IGA Glomerulonephritis
|
112 | 0.645 | 0.560 | 1 | 196673103 | missense variant | G/A | snv | 0.32 | 0.40 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
Lupus Nephritis
|
52 | 0.645 | 0.560 | 1 | 196673103 | missense variant | G/A | snv | 0.32 | 0.40 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
Nephritis
|
39 | 0.645 | 0.560 | 1 | 196673103 | missense variant | G/A | snv | 0.32 | 0.40 | 0.010 | 1.000 | 1 | 2011 | 2011 |